GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » Total Receivables

NGNE (Neurogene) Total Receivables : $0.67 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene Total Receivables?

Neurogene's Total Receivables for the quarter that ended in Sep. 2024 was $0.67 Mil.


Neurogene Total Receivables Historical Data

The historical data trend for Neurogene's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene Total Receivables Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
Total Receivables
0.79 0.99 0.60

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.60 0.59 0.65 0.67

Neurogene Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Neurogene Total Receivables Related Terms

Thank you for viewing the detailed overview of Neurogene's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurogene Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.